News About: Goverment
Health insurance prices of 522 drugs to be lowered from next month
Under the price-cut measure on the 522 pharmaceuticals, the prices of eight original brand medicines will be lowered as their first generic versions entered the market. Prices of six items were also voluntarily ...
Government to make public reimbursable drugs in two therapeutic categories
The Health Insurance Review Agency will unveil the results of 295 medicines falling into two therapeutic categories (anti-hyperlipidemic and anti-migraine agents) in December.
In a workshop on September 20, a HIR...
Hospitals overprescribe drugs
Hospitals continue to overprescribe drugs for treatment of minor diseases such as common cold.
According to a report by the Health Insurance Review Agency (HIRA), the number of prescription in clinics on average wa...
KHIDI to promote ISP project
The Korea Health Industry Development Institute plans to push up with its project for Development Strategy and Planning (ISP) in healthcare industry in a bid to support domestic healthcare industry as national strateg...
Parties agree on parliamentary inspection from October 17
The ruling and opposition parties agreed to commence their parliamentary inspection schedule from October 17 to November 2.
Under the schedule, the Ministry of Health and Welfare will receive the parliamentary audi...
New GMP plan to be delayed
The new GMP (good manufacturing practice) and validation plan, aimed at upgrading Korea's GMP level to international level, will be delayed one month later due to a three-week review period in the Ministry of Governme...
Doctors rally over new prescription dispute
20 doctors staged rallies on September 17 to protest a new prescription rule which they claim will reduce their voice in patients' choices of pharmaceuticals.
The new measure, which has carried out on a trial basis...
Korea, EU to face contentious FTA on pharmaceuticals
Korea and the European Union (EU) are to launch their third round of negotiations in Brussels on September 17, but they will face contentious issues, including pharmaceuticals, according to government sources.
Nego...
Coenzyme Q10 cosmetics are winning consumer's attention
People's demand for coenzyme Q10 cosmetics are expected to increase as coenzyme Q10 is said to be the most promising ingredient in cosmetic products, being able to noticeably postpone skin aging.
Its effect is bas...
Three antihypertensive agents get green light for clinical trails
The Korea Food and Drug Administration said that three drug makers were given the green light to conduct the clinical tests of three different antihypertensive drugs between August 29 and September 2.
1) Jeil Pharm...
